JPRN-jRCT2080224778已完成1 期
Phase I Study of RTA 402 in Obese Adults
试验速览
- 阶段
- 1 期
- 状态
- 已完成
- 入组人数
- 18
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- >= 20age old 至 <= 49age old（—）
- 性别
- Male
入选标准
- •1) Written voluntary informed consent to participate in the study
- •2) Male aged >= 20 and < 50 years at the time of consent
- •3) BMI >= 25.0 kg/m2 measured at screening
- •4) Waist circumference (umbilical position) >= 85 cm measured at screening.
- •5) MRI-measured visceral fat area >= 100 cm2 measured at screening
排除标准
- •1) Subjects who have undergone weight control procedures (weight loss medicine, surgical therapy, exercise therapy, bariatric diet, etc.) at a medical institution within 3 months before the screening
- •2) Subjects with conditions requiring treatment other than obesity
- •3) History of cardiac failure (e.g., a prior diagnosis of congestive cardiac failure defined as NYHA class III or IV or a history of hospitalization for cardiac failure)
研究者
相似试验
已完成
1 期
A Study of RTA 402 in Obese AdultsObese Adult MaleNCT04018339Kyowa Kirin Co., Ltd.22
未知
3 期
Phase III Study of ATL-962 in Obese PatientsObesityJPRN-jRCT2080221428Takeda Pharmaceutical Company Limited
未知
3 期
A phase III study of ATL-962 in subject with obesityObesityJPRN-jRCT2080220827Takeda Pharmaceutical Company Limited
已完成
2 期
Efficacy and Safety of THR-4109 in Obese SubjectsObesityNCT00485017Theracos220
已完成
1 期
A Clinical Pharmacology Study of Bardoxolone Methyl in Healthy AdultsHealthy subjectJPRN-jRCT2080224786Kyowa Kirin Co., Ltd.64